These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35567887)

  • 21. Malignant Peripheral Nerve Sheath Tumor of the Femur: A Rare Diagnosis Supported by Complete Immunohistochemical Loss of H3K27me3.
    Sugawara M; Kobayashi E; Asano N; Yoshida A; Kawai A
    Int J Surg Pathol; 2017 Oct; 25(7):629-634. PubMed ID: 28508686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant Peripheral Nerve Sheath Tumors Show Decreased Global DNA Methylation.
    Nix JS; Haffner MC; Ahsan S; Hicks J; De Marzo AM; Blakeley J; Raabe EH; Rodriguez FJ
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):958-963. PubMed ID: 30169729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.
    Makise N; Sekimizu M; Kubo T; Wakai S; Hiraoka N; Komiyama M; Fukayama M; Kawai A; Ichikawa H; Yoshida A
    Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation
    Panse G; Mito JK; Ingram DR; Wani K; Khan S; Lazar AJ; Doyle LA; Wang WL
    Histopathology; 2021 Jan; 78(2):321-326. PubMed ID: 32735735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of H3K27me3 occurs in a large subset of embryonal rhabdomyosarcomas: Immunohistochemical and molecular analysis of 25 cases.
    Tomassen T; Kester LA; Tops BB; Driehuis E; van Noesel MM; van Ewijk R; van Gorp JM; Hulsker CC; Terwisscha-van Scheltinga SEJ; Merks HHM; Flucke U; Hiemcke-Jiwa LS
    Ann Diagn Pathol; 2021 Jun; 52():151735. PubMed ID: 33770660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of Histone H3K27 Trimethylation (H3K27me3) Expression as a Potential Diagnostic Pitfall in Sarcomatoid Carcinoma.
    Zilla ML; John I; Naous R
    Int J Surg Pathol; 2024 Sep; 32(6):1089-1094. PubMed ID: 37997394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
    Lee W; Teckie S; Wiesner T; Ran L; Prieto Granada CN; Lin M; Zhu S; Cao Z; Liang Y; Sboner A; Tap WD; Fletcher JA; Huberman KH; Qin LX; Viale A; Singer S; Zheng D; Berger MF; Chen Y; Antonescu CR; Chi P
    Nat Genet; 2014 Nov; 46(11):1227-32. PubMed ID: 25240281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of H3K27me3 immunohistochemistry and combination of NF1 and p16 deletions by fluorescence in situ hybridization in the differential diagnosis of malignant peripheral nerve sheath tumor and its histological mimics.
    Sugita S; Aoyama T; Emori M; Kido T; Takenami T; Sakuraba K; Terai K; Sugawara T; Tsujiwaki M; Hasegawa T
    Diagn Pathol; 2021 Aug; 16(1):79. PubMed ID: 34461930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRPS1 expression in MPNST is correlated with PRC2 inactivation and loss of H3K27me3.
    Lazcano R; Ingram DR; Panse G; Lazar AJ; Wang WL; Cloutier JM
    Hum Pathol; 2024 Sep; 151():105632. PubMed ID: 39084565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
    Gaspard M; Lamant L; Tournier E; Valentin T; Rochaix P; Terrier P; Ranchere-Vince D; Coindre JM; Filleron T; Le Guellec S
    Histopathology; 2018 Dec; 73(6):969-982. PubMed ID: 30137667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CDX2 expression in malignant peripheral nerve sheath tumour: a potential diagnostic pitfall associated with PRC2 inactivation.
    Odeyemi OO; Ozawa MG; Charville GW
    Histopathology; 2022 May; 80(6):995-1000. PubMed ID: 35122289
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Oppel F; Ki DH; Zimmerman MW; Ross KN; Tao T; Shi H; He S; Aster JC; Look AT
    Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32651197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications.
    Lu VM; Marek T; Gilder HE; Puffer RC; Raghunathan A; Spinner RJ; Daniels DJ
    J Neurooncol; 2019 Sep; 144(3):433-443. PubMed ID: 31342317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenomic Reordering Induced by Polycomb Loss Drives Oncogenesis but Leads to Therapeutic Vulnerabilities in Malignant Peripheral Nerve Sheath Tumors.
    Wojcik JB; Marchione DM; Sidoli S; Djedid A; Lisby A; Majewski J; Garcia BA
    Cancer Res; 2019 Jul; 79(13):3205-3219. PubMed ID: 30898839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours.
    Asano N; Yoshida A; Ichikawa H; Mori T; Nakamura M; Kawai A; Hiraoka N
    Histopathology; 2017 Feb; 70(3):385-393. PubMed ID: 27580378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
    Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
    Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superficial malignant peripheral nerve sheath tumor with overlying intradermal melanocytic nevus mimicking spindle cell melanoma.
    Jackson CR; Minca EC; Kapil JP; Smith SC; Billings SD
    J Cutan Pathol; 2016 Dec; 43(12):1220-1225. PubMed ID: 27687011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis.
    Hrycaj SM; Szczepanski JM; Zhao L; Siddiqui J; Thomas DG; Lucas DR; Patel RM; Harms PW; Bresler SC; Chan MP
    Histopathology; 2022 Dec; 81(6):818-825. PubMed ID: 36102613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
    Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
    Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms.
    Reuss DE; Habel A; Hagenlocher C; Mucha J; Ackermann U; Tessmer C; Meyer J; Capper D; Moldenhauer G; Mautner V; Frappart PO; Schittenhelm J; Hartmann C; Hagel C; Katenkamp K; Petersen I; Mechtersheimer G; von Deimling A
    Acta Neuropathol; 2014 Apr; 127(4):565-72. PubMed ID: 24464231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.